In silico design of effective inhibitors for α-tubulin

被引:0
|
作者
Diraviyam, Karthikeyan [1 ]
Sept, David [1 ]
机构
[1] Washington Univ, Ctr Computat Biol, St Louis, MO 63110 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
186-MEDI
引用
收藏
页码:509 / 509
页数:1
相关论文
共 50 条
  • [21] Design and Synthesis of Aminostilbene-Arylpropenones as Tubulin Polymerization Inhibitors
    Kamal, Ahmed
    Kumar, G. Bharath
    Polepalli, Sowjanya
    Shaik, Anver Basha
    Reddy, Vangala Santhosh
    Reddy, M. Kashi
    Reddy, Ch. Ratna
    Mahesh, Rasala
    Kapure, Jeevak Sopanrao
    Jain, Nishant
    CHEMMEDCHEM, 2014, 9 (11) : 2565 - 2579
  • [22] In Silico Approaches to the Design of NS5A Inhibitors
    Ivanenkov, Yan A.
    Veselov, Mark S.
    Aladinskiy, Vladimir A.
    Shakhbazyan, Artem G.
    Yartseva, Sofya M.
    Majouga, Alexander G.
    Aladinskaya, Anastasia V.
    Vantskul, Anton S.
    Leonov, Sergey V.
    Ivachtchenko, Alexandre V.
    Koteliansky, Victor E.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (12) : 1383 - 1391
  • [23] In Silico Design of New Inhibitors Against Hemagglutinin of Influenza
    Perrier, Aurelie
    Eluard, Matthias
    Petitjean, Michel
    Vanet, Anne
    JOURNAL OF PHYSICAL CHEMISTRY B, 2019, 123 (03): : 582 - 592
  • [24] In silico design of protein Kinase inhibitors: Successes and failures
    Kiev National University, Kiev, Ukraine
    不详
    不详
    Recent Adv. Electr. Electron. Eng., 2007, 2 (171-188):
  • [25] In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
    Gagic, Zarko
    Ruzic, Dusan
    Djokovic, Nemanja
    Djikic, Teodora
    Nikolic, Katarina
    FRONTIERS IN CHEMISTRY, 2020, 7
  • [26] In silico design of protein kinase inhibitors:: Successes and failures
    Dubinina, Galina G.
    Chupryna, Olkesandr O.
    Platonov, Maxim O.
    Borisko, Petro O.
    Ostrovska, Galina V.
    Tolmachov, Andriy O.
    Shtil, Alexander A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (02) : 171 - 188
  • [27] Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin
    Kim, Do Yoon
    Kim, Kyun-Hwan
    Kim, Nam Doo
    Lee, Ki Young
    Han, Cheol Kyu
    Yoon, Jeong Hyeok
    Moon, Seung Kee
    Lee, Sung Sook
    Seong, Baik L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (19) : 5664 - 5670
  • [28] Safe and Effective Kinase Inhibitors for the Treatment of Gynecological Cancers: In Silico Approach
    Patil, Vaishali M.
    Kumar, Abhishek
    Anand, Vaishali
    Bansal, Priya
    Masand, Neeraj
    CURRENT DRUG METABOLISM, 2021, 22 (07) : 537 - 549
  • [29] In-silico Design of Safe and Effective Topoisomerase IB Inhibitors from Parent Compounds Isolated from Annona muricata
    Adeyemi, Emmanuel Tofunmi
    James, Ayorinde Babatunde
    Odeyemi, Oluwatimilehin Ademilolani
    Magbagbeola, Olubunmi Abiola
    FASEB JOURNAL, 2018, 32 (01):
  • [30] Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors
    Zhang, Sisi
    Mo, Min
    Lv, Mengfan
    Xia, Wen
    Liu, Kun
    Yu, Gang
    Yu, Jia
    Xu, Guangcan
    Zeng, Xiaoping
    Cheng, Sha
    Xu, Bixue
    Luo, Heng
    Meng, Xueling
    FUTURE MEDICINAL CHEMISTRY, 2023, 15 (21) : 1967 - 1986